000999.SZ
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 23.60
−2.24%Sep 11, 2026, 04:16 UTC
China Resources Pharmaceutical's subsidiary China Resources Sanjiu received approval from the National Medical Products Administration to launch mupirocin ointment in mainland China.
Source:Sep 4, 2026, 13:59 UTC
China Resources Sanjiu held an investor research meeting on September 4, 2026, in connection with its 2026 interim results briefing, attended by its chairman, president, CFO, and other executives.
Source:Aug 21, 2026, 11:15 UTC
China Resources Sanjiu disclosed its semi-annual report on August 21, reporting net profit attributable to shareholders of 1.671 billion yuan, down 7.96% year-on-year.
Source:Aug 21, 2026, 11:15 UTC
China Resources Sanjiu announced a cash dividend of 4.15 yuan per 10 shares (tax included) for all shareholders, with no bonus shares or capital reserve conversion.
Source: